Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants (Q24188043)

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Neonatal infection and long-term neurodevelopmental outcome in the preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

The role of nuclear factor-kappa B in cytokine gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Estimating the causes of 4 million neonatal deaths in the year 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Necrotising enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Lactoferrin and the newborn: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Lactoferrin for prevention of neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Molecular cloning and sequence analysis of bovine lactotransferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Inflammatory mechanisms in neonatal chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Bovine lactoferrin and lactoferricin derived from milk: production and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Antibacterial prophylaxis with lactoferrin in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Lactoferrin: an important host defence against microbial and viral attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Hospital-acquired neonatal infections in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

Phase I trial of oral talactoferrin alfa in refractory solid tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

Lactoferrin protects neonatal rats from gut-related systemic infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007137.PUB4

7 January 2021

10.1002/14651858.CD007137.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2602355

2602355

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference